Your browser is no longer supported. Please, upgrade your browser.
Settings
TGTX TG Therapeutics, Inc. daily Stock Chart
TGTX [NASD]
TG Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.13 Insider Own1.30% Shs Outstand86.05M Perf Week-7.09%
Market Cap439.72M Forward P/E- EPS next Y-2.12 Insider Trans-6.07% Shs Float72.85M Perf Month-43.22%
Income-148.10M PEG- EPS next Q-0.54 Inst Own56.70% Short Float14.28% Perf Quarter-55.57%
Sales0.20M P/S2198.58 EPS this Y-19.60% Inst Trans0.49% Short Ratio6.76 Perf Half Y-64.39%
Book/sh1.37 P/B3.73 EPS next Y1.40% ROA-128.50% Target Price18.67 Perf Year-40.58%
Cash/sh1.47 P/C3.48 EPS next 5Y- ROE-177.80% 52W Range4.95 - 17.35 Perf YTD-37.68%
Dividend- P/FCF- EPS past 5Y-6.70% ROI-176.90% 52W High-70.55% Beta1.54
Dividend %- Quick Ratio3.70 Sales past 5Y51.60% Gross Margin- 52W Low3.23% ATR0.53
Employees96 Current Ratio3.70 Sales Q/Q0.00% Oper. Margin- RSI (14)24.70 Volatility6.30% 8.20%
OptionableYes Debt/Eq0.00 EPS Q/Q-32.70% Profit Margin- Rel Volume1.08 Prev Close5.37
ShortableYes LT Debt/Eq0.00 EarningsNov 07 BMO Payout- Avg Volume1.54M Price5.11
Recom1.70 SMA20-9.90% SMA50-44.07% SMA200-58.03% Volume1,668,962 Change-4.84%
Sep-25-18Downgrade Raymond James Strong Buy → Outperform
Mar-09-18Reiterated B. Riley FBR, Inc. Buy $21.50 → $27
Dec-01-17Resumed B. Riley FBR, Inc. Buy $21.50
Nov-14-17Resumed H.C. Wainwright Buy $33
Apr-25-17Initiated Jefferies Buy
Mar-06-17Reiterated FBR & Co. Outperform $24 → $26
Oct-06-16Resumed Brean Capital Buy $28
May-27-16Initiated SunTrust Buy $18
Dec-01-15Initiated FBR Capital Outperform $29
Sep-09-15Initiated Raymond James Strong Buy
Aug-12-15Resumed H.C. Wainwright Buy $22
Jun-19-15Reiterated Brean Capital Buy $22 → $28
Dec-11-14Reiterated ROTH Capital Buy $25 → $33
Dec-10-14Reiterated ROTH Capital Buy $25 → $33
Oct-27-14Initiated H.C. Wainwright Buy $17
Sep-25-14Reiterated Brean Capital Buy $19 → $22
Jul-22-14Reiterated Brean Capital Buy $13 → $19
Jul-02-14Reiterated MLV & Co Buy $10 → $16
Apr-04-14Initiated Brean Capital Buy $13
Mar-07-14Reiterated MLV & Co Buy $9 → $11
Oct-22-18 02:19PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CBS, COCP, TGTX and TRVN GlobeNewswire
12:32PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against TG Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Oct-21-18 11:00AM  SHAREHOLDER ALERT: AMPE NVRO PZZA OPK QRTEA MCHP COCP TGTX CPB TRVN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Oct-19-18 06:41PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of TG Therapeutics, Inc. - TGTX GlobeNewswire
02:45PM  INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against TG Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Oct-18-18 11:40AM  CLASS ACTION UPDATE for TGTX, MGTI, SFIX and GOOG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TG Therapeutics, Inc. (TGTX) GlobeNewswire
Oct-17-18 05:53PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TG Therapeutics, Inc. - TGTX PR Newswire
02:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PZZA, TGTX, MGTI, CHGG and GOOG GlobeNewswire
Oct-16-18 07:01PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of TG Therapeutics, Inc. Investors (TGTX) Business Wire
06:00PM  SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against TG Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
04:15PM  TG THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against TG Therapeutics, Inc. GlobeNewswire
07:50AM  Analysis: Positioning to Benefit within Ardelyx, AXT, TG Therapeutics, MarineMax, Oclaro, and BioCryst Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Oct-15-18 03:35PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PDD, QRTEA, TRCO, MCHP, TGTX and CPB GlobeNewswire
01:10PM  TG THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In TG Therapeutics, Inc. To Contact The Firm Business Wire
Oct-14-18 10:05AM  SHAREHOLDER ALERT: QRTEA TRCO PVG USAT COCP TGTX ABBV CPB CHGG ACHC: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Oct-12-18 06:16PM  TGTX LOSS NOTICE: Rosen Law Firm Reminds TG Therapeutics, Inc. Investors of Important Deadline in Class Action TGTX Business Wire
02:00PM  Johnson Fistel Files Class Action Suit against TG Therapeutics, Inc. PR Newswire
01:00PM  CLASS ACTION UPDATE for TGTX and CPB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Oct-11-18 05:15PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against TG Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
04:28PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of TG Therapeutics, Inc. Investors (TGTX) Business Wire
03:34PM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against TG Therapeutics, Inc. Business Wire
02:22PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OPK, TGTX, HAS and CPB GlobeNewswire
11:00AM  TG Therapeutics, Inc. Announces Final Phase 2 Multiple Sclerosis Data Presentation at the 34th Congress of ECTRIMS GlobeNewswire
Oct-10-18 07:31PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MGT Capital, Applied Optoelectronics, and TG Therapeutics and Encourages Investors to Contact the Firm GlobeNewswire
02:59PM  SHAREHOLDER ALERT: LCI CBS PZZA LOGM QRTEA PVG TGTX HAS CPB ACHC: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
01:20PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against TG Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:26PM  Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against TG Therapeutics, Inc. (TGTX) PR Newswire
10:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TG Therapeutics, Inc. (TGTX) GlobeNewswire
09:00AM  Why TG Therapeutics Stock Collapsed Last Month Motley Fool
Oct-09-18 04:34PM  TG THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against TG Therapeutics, Inc. GlobeNewswire +6.45%
03:16PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TGTX, HAS, ACHC and ADNT GlobeNewswire
02:35PM  TG THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In TG Therapeutics, Inc. To Contact The Firm ACCESSWIRE
10:45AM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against TG Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
09:41AM  3 Biotech Stocks With Major Incoming Catalysts Motley Fool
Oct-08-18 04:18PM  Robbins Arroyo LLP: TG Therapeutics, Inc. (TGTX) Misled Shareholders According to a Class Action Business Wire
02:30PM  CLASS ACTION UPDATE for TGTX and ADNT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:30PM  INVESTOR ALERT: Ademi & O'Reilly, LLP Reminds Investors in TG Therapeutics, Inc. (TGTX) of December 3 Deadline PR Newswire
10:25AM  IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against TG Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
07:30AM  The Week Ahead In Biotech: Conferences, Clinical Trial Results And IPOs Benzinga
07:30AM  TG Therapeutics, Inc. Highlights Schedule of Events at the Upcoming 34th Congress of ECTRIMS GlobeNewswire
Oct-05-18 08:00PM  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against TG Therapeutics, Inc. (TGTX) GlobeNewswire
04:30PM  TG THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In TG Therapeutics, Inc. To Contact The Firm PR Newswire
03:10PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against TG Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
02:42PM  How Does TG Therapeutics Inc (NASDAQ:TGTX) Affect Your Portfolio Returns? Simply Wall St.
11:11AM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against TG Therapeutics, Inc. Business Wire
10:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against TG Therapeutics, Inc. (TGTX) GlobeNewswire
Oct-04-18 08:06PM  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against TG Therapeutics, Inc. (TGTX) and Encourages TGTX Investors to Contact the Firm GlobeNewswire
06:50PM  Kaskela Law LLC Announces Shareholder Class Action Lawsuit Filed Against TG Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm TGTX GlobeNewswire
05:11PM  Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against TG Therapeutics, Inc. Business Wire
03:51PM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against TG Therapeutics, Inc. (TGTX) PR Newswire
Sep-28-18 10:05AM  TG Therapeutics (TGTX) in Focus: Stock Moves 8.6% Higher Zacks
07:30AM  TG Therapeutics, Inc. to Present at Upcoming Investor Conferences GlobeNewswire
Sep-26-18 04:56PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of TG Therapeutics, Inc. GlobeNewswire
08:00AM  Today's Research Reports on Trending Tickers: Jaguar Health and TG Therapeutics ACCESSWIRE
08:00AM  TG Therapeutics, Inc. Announces Final Phase 2 Multiple Sclerosis Data Accepted for Oral Presentation at the Upcoming 34th Congress of ECTRIMS GlobeNewswire
01:00AM  TG Therapeutics (TGTX) Alert: Johnson Fistel Investigates TG Therapeutics, Inc.; Investors Encouraged to Contact the Firm PR Newswire
Sep-25-18 11:39AM  A Big Disappointment Sends TG Therapeutics Stock Skidding 34% Today Motley Fool -44.32%
07:00AM  TG Therapeutics Announces Update Regarding UNITY-CLL Phase 3 Trial GlobeNewswire
Sep-21-18 08:46AM  Implied Volatility Surging for TG Therapeutics (TGTX) Stock Options Zacks
Sep-18-18 08:00AM  Todays Research Reports on Stocks to Watch: Teva Pharmaceutical and TG Therapeutics ACCESSWIRE
Aug-26-18 03:40PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Results Benzinga
Aug-23-18 11:50AM  New York City stocks that are driving Wall Street's latest bull run American City Business Journals
Aug-21-18 03:28AM  Edited Transcript of TGTX earnings conference call or presentation 7-Aug-18 8:30pm GMT Thomson Reuters StreetEvents +5.65%
Aug-20-18 08:39AM  Is the Options Market Predicting a Spike in TG Therapeutics (TGTX) Stock? Zacks
Aug-15-18 07:40AM  Consolidated Research: 2018 Summary Expectations for Allegiance Bancshares, TG Therapeutics, JELD-WEN Holding, Eagle Bulk Shipping, Bryn Mawr Bank, and Surmodics Fundamental Analysis, Key Performance Indications GlobeNewswire
Aug-13-18 08:17AM  3 Biotech Stocks With Major Catalysts Incoming Motley Fool
Aug-07-18 04:17PM  TG Therapeutics: 2Q Earnings Snapshot Associated Press
04:00PM  TG Therapeutics, Inc. Provides Business Update and Reports Second Quarter 2018 Financial Results GlobeNewswire
07:30AM  TG Therapeutics Announces Completion of Target Enrollment in the ULTIMATE Phase 3 Trials in Multiple Sclerosis GlobeNewswire
Aug-06-18 07:30AM  TG Therapeutics, Inc. to Host Conference Call on Second Quarter 2018 Financial Results and Business Update GlobeNewswire
Jul-10-18 08:40AM  Implied Volatility Surging for TG Therapeutics (TGTX) Stock Options Zacks
07:35AM  Complimentary Technical Snapshots on Trevena and Three More Biotech Stocks ACCESSWIRE
Jun-20-18 07:30AM  TG Therapeutics and Novimmune SA Announce Global Agreement for Development and Commercialization of a Novel Anti-CD47/ Anti-CD19 Bispecific Antibody GlobeNewswire
Jun-18-18 12:00PM  TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab in Patients with Multiple Sclerosis at the 4th Congress of the European Academy of Neurology GlobeNewswire
07:30AM  TG Therapeutics, Inc. Presents Phase 2 Data Evaluating Umbralisib in CLL Patients Intolerant to Prior BTK or PI3K Delta Inhibitor Therapy at the 23rd Congress of the European Hematology Association (EHA) GlobeNewswire
Jun-15-18 09:17AM  TG Therapeutics, Inc. Announces Clinical and Preclinical Data Presentations at the 23rd Congress of the European Hematology Association GlobeNewswire
08:13AM  TG Therapeutics, Inc. Announces Oral Presentation of Umbralisib plus Ruxolitinib in Patients with Myelofibrosis at the 23rd Congress of the European Hematology Association GlobeNewswire
Jun-12-18 04:29PM  This Biotech Investors Picks Returned 31% in Q1; Here Are Its New Bets Insider Monkey
Jun-08-18 07:00AM  TG Therapeutics and Three Additional Stocks Under Scanner in the Biotech Space ACCESSWIRE
06:04AM  3 Cancer Stocks That Could Soar in the Second Half of 2018 Motley Fool
Jun-05-18 07:30AM  TG Therapeutics, Inc. to Present at the Jefferies 2018 Global Healthcare Conference GlobeNewswire
Jun-04-18 04:06PM  ASCO 2018 Sends TG Therapeutics Stock Soaring 10% Today Motley Fool +10.78%
09:00AM  TG Therapeutics, Inc. Announces Umbralisib Clinical Data Presentation at the 54th Annual Meeting of the American Society of Clinical Oncology GlobeNewswire
07:30AM  TG Therapeutics, Inc. Appoints Adam Waldman as Chief Commercial Officer GlobeNewswire
Jun-01-18 07:30AM  TG Therapeutics, Inc. Recaps Upcoming Data Presentations at the 54th Annual Meeting of the American Society of Clinical Oncology and the 23rd Congress of the European Hematology Association GlobeNewswire
May-17-18 09:10AM  TG Therapeutics, Inc. Announces Upcoming Data Presentations at the 54th Annual Meeting of the American Society of Clinical Oncology and the 23rd Congress of the European Hematology Association GlobeNewswire
May-14-18 07:51PM  Edited Transcript of TGTX earnings conference call or presentation 8-May-18 12:30pm GMT Thomson Reuters StreetEvents +5.34%
May-08-18 07:53AM  TG Therapeutics: 1Q Earnings Snapshot Associated Press -6.51%
07:30AM  TG Therapeutics, Inc. Provides Business Update and Reports First Quarter 2018 Financial Results GlobeNewswire
May-04-18 07:30AM  TG Therapeutics, Inc. to Host Conference Call on First Quarter 2018 Financial Results and Business Update GlobeNewswire
Apr-30-18 08:20AM  Recent Analysis Shows FTD Companies, TG Therapeutics, National HealthCare, Lennox International, PRA Group, and Unit Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Apr-24-18 08:06AM  TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab (TG-1101) in Patients with Multiple Sclerosis at the American Academy of Neurology 70th Annual Meeting GlobeNewswire
Apr-20-18 08:03AM  3 Biotech Stocks With Major Catalysts Incoming Motley Fool
Apr-18-18 09:00AM  TG Therapeutics, Inc. Announces Preclinical Data Presentation on the Companys BET Inhibitor, TG-1601, at the 2018 American Association for Cancer Research (AACR) Annual Meeting GlobeNewswire
Apr-16-18 07:00AM  Stemline Therapeutics Expands Board of Directors; Further Enhances Commercial Expertise with Appointment of Darren Cline GlobeNewswire
Mar-26-18 07:30AM  TG Therapeutics, Inc. to Present at the Needham 17th Annual Healthcare Conference GlobeNewswire
Mar-15-18 07:30AM  TG Therapeutics, Inc. Announces Preclinical Data Presentation at the 2018 American Association for Cancer Research (AACR) Annual Meeting GlobeNewswire
Mar-09-18 02:21PM  Edited Transcript of TGTX earnings conference call or presentation 8-Mar-18 1:30pm GMT Thomson Reuters StreetEvents
Mar-08-18 09:36AM  TG Therapeutics reports 4Q loss Associated Press +7.87%
TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases in the United States. It develops TG-1101 (ublituximab), a chimeric, glycoengineered monoclonal antibody that targets an epitope on the CD20 antigen found on the surface of B-lymphocytes developed to aid in the depletion of circulating B-cells; and TG-1101 in combination with TGR-1202 for relapsed/refractory chronic lymphocytic leukemia. The company also develops TGR-1202, an orally available phosphoinositide-3-kinase delta inhibitor with nanomolar potency to the delta isoform and high selectivity over the alpha, beta, and gamma isoforms, as well as for hematologic malignancies. In addition, it develops a pre-clinical program to develop interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors; bromodomain and extra terminal (BET) inhibitor program for cancer treatment; and anti-PD-L1 and anti-GITR antibody research programs that are in pre-clinical development stage in the field of hematological malignancies. The company has license agreements with LFB Biotechnologies S.A.S, GTC Biotherapeutics, LFB/GTC LLC, and Ildong Pharmaceutical Co. Ltd. for the development and commercialization of TG-1101 (ublituximab); Rhizen Pharmaceuticals, SA for the development and commercialization of TGR-1202; Ligand Pharmaceuticals Incorporated for the development and commercialization of IRAK4 inhibitor technology; Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs; and Jubilant Biosys for the development and commercialization of BET inhibitor program. TG Therapeutics, Inc. was incorporated in 1993 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Power Sean ACFO, Secretary and TreasurerJul 03Sale13.1935,000461,650438,267Jul 05 05:00 PM
Power Sean ACFO, Secretary and TreasurerJul 02Sale13.2612,191161,653473,267Jul 05 05:00 PM
KENNEDY WILLIAM JAMESDirectorJun 14Sale13.4525,071337,20560,330Jun 18 04:30 PM
Power Sean ACFO, Secretary and TreasurerJan 02Sale8.5032,006272,051485,458Jan 03 05:25 PM